S1232 The TOUCH™ Program and Risk Management Plan for the Administration of Natalizumab: Lessons and Updated Safety Results from the Use of Natalizumab in Patients with Relapsing Multiple Sclerosis and Implications for Potential Use in Crohn's Disease

✍ Scribed by Bruce E. Sands; Gordon Francis; Glyn Belcher; Mariska Kooijmans; Richard Kim; Frances Lynn; Carmen Bozic; William Maier; Jean-Frédéric Colombel

• Book ID: 119428825
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 102 KB
• Volume: 134
• Category: Article
• ISSN: 0016-5085
• DOI: 10.1016/s0016-5085(08)60954-3